Inventor · disambiguated record
Osama Suleiman
Also filed as: SULEIMAN OSAMA
13 granted patents·7 pending applications·35 citations·filing 2016–2025
87Inventor score
Top patents by PatentIndex Score
20 records- 0195US11866434B2Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereofINCYTE CORP·Filed 2021·Granted Jan 9, 2024·7 cites·41 claims
- 0293US10414732B2Polymorphic compounds and uses thereofALDEYRA THERAPEUTICS INC·Filed 2018·Granted Sep 17, 2019·20 cites·15 claims
- 0388US11267795B2Crystalline PPAR-delta agonistRENEO PHARMACEUTICALS INC·Filed 2021·Granted Mar 8, 2022·4 cites·16 claims
- 0483US12209073B2Polymorphs of a dihydroorotate dehydrogenase (DHOD) inhibitorKIORA PHARMACEUTICALS GMBH·Filed 2023·Granted Jan 28, 2025·2 cites·20 claims
- 0582US2025333416A1Process for making a pd-1/pd-l1 inhibitor and salts and crystalline forms thereofINCYTE CORP·Filed 2025·Application pending·0 cites
- 0678US12404272B2Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereofINCYTE CORP·Filed 2023·Granted Sep 2, 2025·0 cites·13 claims
- 0774US12152034B2FGFR inhibitors and methods of making and using the sameRELAY THERAPEUTICS INC·Filed 2021·Granted Nov 26, 2024·1 cites·19 claims
- 0872US10934260B2Method for producing a polymorphic form of 3-[5-amino-4-(3- cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamideMEREO BIOPHARMA 1 LTD·Filed 2017·Granted Mar 2, 2021·1 cites·16 claims
- 0970US2022033408A1Process for preparing spiro derivativesBIOGEN INC·Filed 2021·Application pending·0 cites
- 1070US2024002356A1Crystalline ppar-delta agonistRENEO PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1169US2022242868A1Co-crystals of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2021·Application pending·0 cites
- 1267US11713301B2Crystalline PPARδ agonistRENEO PHARMACEUTICALS INC·Filed 2022·Granted Aug 1, 2023·0 cites·19 claims
- 1363US12491182B2Polymorphs of triazole antifungal compound PC945PULMOCIDE LTD·Filed 2020·Granted Dec 9, 2025·0 cites·5 claims
- 1463US11149039B2Process for preparing spiro derivativesBIOGEN INC·Filed 2018·Granted Oct 19, 2021·0 cites·19 claims
- 1560US11434204B2Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamideMEREO BIOPHARMA 1 LTD·Filed 2021·Granted Sep 6, 2022·0 cites·6 claims
- 1658US2020031829A1Co-crystals of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 1758US2025243204A1Fgfr inhibitors and methods of making and using the sameRELAY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1849US2018072739A1Co-crystals of a bruton's tyrosine kinase inhibitorPharmacyclic LLC·Filed 2016·Application pending·0 cites
- 1942US12187700B2Polymorphs and cocrystals of a cardiac troponin activatorAMGEN INC·Filed 2020·Granted Jan 7, 2025·0 cites·39 claims
- 2041US10995071B2Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamideMEREO BIOPHARMA 1 LTD·Filed 2017·Granted May 4, 2021·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Osama Suleiman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →